Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$14.08 - $27.63 $450 - $884
-32 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$26.55 - $40.57 $849 - $1,298
32 New
32 $1,000
Q3 2021

Nov 12, 2021

SELL
$39.27 - $72.94 $2.12 Million - $3.93 Million
-53,943 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$31.29 - $56.64 $90,741 - $164,256
-2,900 Reduced 5.1%
53,943 $3.06 Million
Q1 2021

May 11, 2021

BUY
$39.71 - $90.58 $345,477 - $788,046
8,700 Added 18.07%
56,843 $2.39 Million
Q4 2020

Feb 12, 2021

BUY
$27.07 - $84.35 $235,509 - $733,845
8,700 Added 22.06%
48,143 $3.38 Million
Q3 2020

Nov 12, 2020

BUY
$28.06 - $37.16 $73,236 - $96,987
2,610 Added 7.09%
39,443 $1.11 Million
Q2 2020

Aug 12, 2020

BUY
$18.5 - $34.34 $59,015 - $109,544
3,190 Added 9.48%
36,833 $1.09 Million
Q1 2020

May 13, 2020

SELL
$14.88 - $32.78 $4,315 - $9,506
-290 Reduced 0.85%
33,643 $667,000
Q4 2019

Feb 11, 2020

SELL
$19.49 - $32.63 $22,608 - $37,850
-1,160 Reduced 3.31%
33,933 $1.01 Million
Q3 2019

Nov 12, 2019

SELL
$22.49 - $26.81 $13,044 - $15,549
-580 Reduced 1.63%
35,093 $798,000
Q2 2019

Aug 14, 2019

BUY
$20.48 - $27.76 $11,878 - $16,100
580 Added 1.65%
35,673 $883,000
Q1 2019

May 07, 2019

BUY
$19.43 - $26.41 $112,694 - $153,178
5,800 Added 19.8%
35,093 $858,000
Q4 2018

Feb 12, 2019

BUY
$18.19 - $31.79 $532,839 - $931,224
29,293 New
29,293 $666,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Motley Fool Asset Management LLC Portfolio

Follow Motley Fool Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.